Oric Pharmaceuticals's total assets for Q1 2025 were $242.86M, a decrease of -11.41% from the previous quarter. ORIC total liabilities were $23.12M for the fiscal quarter, a -25.47% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.